2BB score and signals
Taysha Gene Therapies, Inc.’s current 2BB score is 28 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 23 | Low |
| Momentum | 63 | Improving |
| Financial strength | 29 | Weak |
| Quality | 80 | Very Strong |
| Risk | 46 | Moderate |
Company facts
| Headquarters | Dallas, Texas, United States |
| Founded | 2019 |
| Employees | 99 |
| 52-week range | $3.46 – $7.30 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-17 | — | -0.1331 | — | $306,000.00 |
| 2026-11-02 | — | -0.1326 | — | $630,543.00 |
| 2026-08-11 | -0.13 | -0.1189 | $0.00 | $693,600.00 |
| 2026-05-06 | -0.12 | -0.0996 | $0.00 | $693,600.00 |
Related companies
2BBBullish & Bearish